1. Home
  2. APLM vs OLB Comparison

APLM vs OLB Comparison

Compare APLM & OLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLM
  • OLB
  • Stock Information
  • Founded
  • APLM 2016
  • OLB 1993
  • Country
  • APLM United States
  • OLB United States
  • Employees
  • APLM N/A
  • OLB N/A
  • Industry
  • APLM Blank Checks
  • OLB EDP Services
  • Sector
  • APLM Finance
  • OLB Technology
  • Exchange
  • APLM Nasdaq
  • OLB Nasdaq
  • Market Cap
  • APLM 6.9M
  • OLB 5.9M
  • IPO Year
  • APLM N/A
  • OLB N/A
  • Fundamental
  • Price
  • APLM $6.41
  • OLB $1.85
  • Analyst Decision
  • APLM
  • OLB
  • Analyst Count
  • APLM 0
  • OLB 0
  • Target Price
  • APLM N/A
  • OLB N/A
  • AVG Volume (30 Days)
  • APLM 4.6K
  • OLB 152.0K
  • Earning Date
  • APLM 08-13-2025
  • OLB 08-13-2025
  • Dividend Yield
  • APLM N/A
  • OLB N/A
  • EPS Growth
  • APLM N/A
  • OLB N/A
  • EPS
  • APLM N/A
  • OLB N/A
  • Revenue
  • APLM $198,000.00
  • OLB $11,664,342.00
  • Revenue This Year
  • APLM $415.15
  • OLB N/A
  • Revenue Next Year
  • APLM N/A
  • OLB N/A
  • P/E Ratio
  • APLM N/A
  • OLB N/A
  • Revenue Growth
  • APLM N/A
  • OLB N/A
  • 52 Week Low
  • APLM $4.47
  • OLB $1.00
  • 52 Week High
  • APLM $35.98
  • OLB $3.34
  • Technical
  • Relative Strength Index (RSI)
  • APLM 51.61
  • OLB 45.63
  • Support Level
  • APLM $5.34
  • OLB $1.61
  • Resistance Level
  • APLM $6.70
  • OLB $2.11
  • Average True Range (ATR)
  • APLM 0.52
  • OLB 0.21
  • MACD
  • APLM -0.03
  • OLB -0.06
  • Stochastic Oscillator
  • APLM 67.65
  • OLB 15.38

About APLM Apollomics Inc.

Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.

About OLB The OLB Group Inc.

The OLB Group Inc is a diversified fintech e-commerce merchant services provider and Bitcoin crypto mining enterprise. It focuses on a suite of products in the merchant services marketplace and seeks to provide integrated business solutions to merchants throughout the United States. Along with its subsidiaries, the company offers a cloud-based business management platform that provides turnkey solutions for merchants to enable them to build and manage their retail businesses, whether online or at a brick-and-mortar location, payment processing solutions, payment gateway, virtual terminal with proprietary business management tools, and crowdfunding solutions. The company has two business segments; Fintech Services which generates key revenue, and the Bitcoin Mining business segment.

Share on Social Networks: